Dhampur Bio Organics Board to Consider Share Buyback and Q2 Financial Results
Dhampur Bio Organics Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Dhampur Bio Organics Board to Consider Share Buyback and Q2 Financial Results Dhampur Bio Organics Ltd.'s Board of Directors is scheduled to meet on 14th Nov'26 to consider and approve the audited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Crucially for equity markets, the board will also evaluate a proposal for the buyback of equity shares in accordance with SEBI Buy-back of Securities Regulations. Consequently, the trading window for designated persons remains closed until 16th Nov'26.
Original exchange filing (PDF)
More announcements from Dhampur Bio Organics Ltd
- Please find attached the Investor Presentation for the Quarter ended September 30, 2026. 路 15 Nov 2026
- Appointment of Cost Auditor of the Company to fill casual vacancy for the FY 2026-27. 路 14 Nov 2026
- Audited Financial Results for the quarter and half year ended September 30, 2026 路 14 Nov 2026
- Dhampur Bio Organics Limited has submitted to the Exchange, the audited financial results for the period ended September 30, 2026 and approved the buyback subject to the approval of shareholders. 路 14 Nov 2026
- Outcome of Board Meeting held on November 14, 2026 路 14 Nov 2026
- Intimation of Grant of Stock options pursuant to DBO Employee Stock Option Scheme 2025 as approved by the Nomination and Remuneration Committee. 路 12 Nov 2026
- Dhampur Bio Organics Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Quarterly Audited Financial results of the Company for the period ended September 2026 and Buyback/Other business. 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and consider buy back of equity shares of the company and other business matters 路 14 Nov 2026
